←
Teijaro Lab51 posts
Teijaro Lab avatar

Teijaro Lab

@Teijaro_Lab

Chronic viral infections, Chemical Immunology, and immuno-oncology @ScrippsResearch

◷ Joined March 2018▧ 10 Photos and videos
Teijaro Lab avatar
Teijaro Lab@Teijaro_Lab·23 Jun 2024

Congrats to everyone involved. @andyjminn, @EJohnWherry, @divijmathew, @zakjerry1 and @Isa57569543. Two great complimentary studies that hopefully will catalyze better treatments for patients in need soon! 👏

In two separate Science studies, researchers report that combining JAK inhibitors with checkpoint inhibitor immunotherapy enhances cancer patient response. Learn more ⬇️ 📄: scim.ag/7p1 📄: scim.ag/7p2 #SciencePerspective: scim.ag/7p0

Post attachment
Nature Biotechnology avatar
⟳ Teijaro Lab retweeted
Nature Biotechnology@NatureBiotech·21 Jun 2024

JAK inhibitors enhance anti–PD-1 immunotherapy by modulating T cell exhaustion and inflammatory signaling, as shown in preclinical models and clinical trials for non-small cell lung cancer and Hodgkin lymphoma.science.org/doi/10.1126/scie… science.org/doi/10.1126/scie… #NBThighlight

Teijaro Lab avatar
Teijaro Lab@Teijaro_Lab·21 Jun 2024

Proud of my two post-docs on their Science paper demonstrating JAK inhibitors can promote better anti-tumor responses in combination with checkpoint immunotherapy. Well done Jerry and Isa as well as all the authors! Special thanks to Dr. Veronika Bachanova for running the trial!

A new @ScienceMagazine study led by Prof. John Teijaro, PhD, found that combining ruxolitinib, an approved drug, with checkpoint inhibitors supercharged T-cell responses. This could transform #cancer treatment, especially for tough-to-treat cancers. More: ow.ly/h7ol50SmP4I

Post attachment
Chris Parker avatar
⟳ Teijaro Lab retweeted
Chris Parker@_chrisgparker_·8 Jan 2024

Excited to share the final version in @nchembio. Lots more mechanistic insights & characterization, including our inhibitors disrupt PPIs with mTOR components & induce lysosomal degradation of SLC15A4, & more. A promising target for autoimmune conditions. nature.com/articles/s41589-0…

Scripps Research avatar
⟳ Teijaro Lab retweeted
Scripps Research@scrippsresearch·16 Mar 2021

Congratulations to @EOSaphire on being newly appointed as President and CEO @ljiresearch. A former graduate student and accomplished faculty member at Scripps Research, we wish her much success in her continued leadership in immunology and virology.

NEWS: Dr. Erica Ollmann Saphire appointed president and CEO of La Jolla Institute for Immunology https://t.co/5tzTwv5XqF #SanDiego #LaJolla #immunology #health #biotech #biomedicine

Post attachment
Teijaro Lab avatar
Teijaro Lab@Teijaro_Lab·21 Aug 2020

Great example of basic research at Scripps and the Calibr drug discovery engine coming together to advance medicines for human disease. Watch this space. Congrats to all involved!

STING attack on #cancer! In work by @Teijaro_Lab & Lairson Lab, Scripps Research scientists discover a drug that can activate the immune-boosting protein STING. Efficacy against #melanoma shows its potential as a future #anticancer therapy scripps.edu/news-and-events/… @ScienceMagazine

Post attachment
Teijaro Lab avatar
Teijaro Lab@Teijaro_Lab·20 Aug 2020

Great day for the lab! Our collaborative work with Luke Larson's lab and Calibr came out today in Science! Congratulations to Vincent, Emily, Ying, and the whole team! We identified and characterized a novel, anti-tumor STING agonist, SR-717. Read it here: science.sciencemag.org/conte…

Post attachmentPost attachmentPost attachmentPost attachment